Ever bet against a company and watched it skyrocket? That’s what happened to Martin Shkreli, who shorted Capricor Therapeutics, only to see its stock rocket 440% after good news about its new treatment for muscular dystrophy. The drama? Shkreli trashed the company’s science, but the market didn’t care—proving that betting against medical breakthroughs can seriously backfire. If you’re playing the stock game, remember: sometimes the underdog wins big! #Business #Market #stocks